On June 7, 2022, the Turkish Medicines and Medical Devices Agency (“Agency”) published the Draft Guidelines on Packaging Information and Legibility of Foods for Special Medical Purposes (“Legibility Guidelines”) and the Draft Guidelines on New Health Claim Applications (“Application Guidelines”).
ODI Advises Mesi on Obtaining Equity Financing
ODI Law has advised Slovenian diagnostic system manufacturer Mesi on a strategic investment from Heine Optotechnik CEO Oliver Heine. EY Law Germany reportedly advised the investor.
Dentons and Glatzova & Co Advise on GeneProof's Merger with ALPC
Dentons has advised GeneProof founders Radek Horvath and Milos Dendis on the company's merger with the American Laboratory Products Company, leading to the establishment of the ALPCO Group. Glatzova & Co and Sidley Austin advised the Silicon Valley Bank on financing the merger. Goodwin Procter and Schoenherr reportedly advised Ampersands, the owner of ALPC.
Sorainen Advises INVL Baltic Sea Growth Fund on Acquisition of Nemunas and Egles Sanatorija
Sorainen has advised the INVL Baltic Sea Growth Fund on its acquisition of the Nemunas and Egles Sanatorija treatment centers in Lithuania.
New Special Taxes in Hungary To Improve the State’s Income
On 4 June 2022 the Hungarian government issued a decree introducing special taxes affecting several sectors, among others banking, insurance, energy, telecommunications and airlines.
D&B David and Baias Advises Fiterman Pharma on Sale of Uractiv Portfolio to Terapia
PwC's Romanian affiliate D&B David and Baias has advised Fiterman Pharma on the sale of its Uractiv product portfolio to Sun Pharma company Terapia. KPMG Legal affiliate Toncescu si Asociatii reportedly advised the buyer.
NKO Partners Advises Dr. Max Group on Acquisition of K-Pharma
NKO Partners has advised the Dr. Max Group on another pharmacy chain acquisition in Serbia – that of Belgrade-based K-Pharma.